8-K - Oragenics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Oragenics, Inc. issued a press release on March 10, 2026, announcing receipt of final Human Research Ethics Committee approval. The company filed an 8-K on March 11, 2026, under Item 8.01 Other Information with exhibits including press releases dated March 10 and March 11, 2026.

Key Takeaways

1Received final Human Research Ethics Committee approval on March 10, 2026.

2Issued press release announcing the approval on March 10, 2026.

3Filed 8-K on March 11, 2026.

4Exhibits: 99.1 Press Release dated March 10, 2026.

5Exhibits: 99.2 Press Release dated March 11, 2026.

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. OTHER INFORMATION. On March 10, 2026, Oragenics, Inc. (the “Company”) issued a press release announcing that it had received final Human Research Ethics Commi

Other Event

9.01

. FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit No. Description 99.1 Press Release dated March 10, 2026. 99.2 Press Release dated March 11, 2026. 99.3

Exhibits Only

Source Document

Exhibits (4)

8-K

99.1

EX-99.1

99.2

EX-99.2

99.3

EX-99.3